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osting by EAbstract Novel pyrimidines were prepared by the condensation of chalcones of 40-piperazine ace-
tophenone with guanidine HCl. The structures of the synthesized compounds RP 1–5 were assigned
on the basis of elemental analysis, IR, 1H NMR and mass spectroscopy. These compounds were
also screened for anti-histaminic activity. The recorded percentage of histamine inhibition showed
a signiﬁcant anti-histaminic activity when compared to the reference anti-histaminic drug mepir-
amine.
ª 2009 King Saud University. All rights reserved.1. Introduction
Pyrimidines are an important class of heterocyclic compounds,
which possess a wide range of biological activities such as anti-
cancer (Mattew et al., 1984; Yamakawa et al., 1990), antibac-
terial (Isida et al., 1960), anti-inﬂammatory (Hogale et al.,
1986), antiviral (Ahluwalia et al., 1987), antitubercular (Bhat
et al., 1972), antihypertensive (Ishitsuka et al., 1982) and anti-
convulsant (Ninomiya et al., 1990) activities.ffmail.com (Sk.A. Rahaman).
ity. All rights reserved. Peer-
d University.
lsevier2. Experimental
All the melting points were determined by a digital melting
point apparatus and were uncorrected. IR spectra were re-
corded on a Perkin–Elmer 377 spectrophotometer, 1H NMR
spectra were measured on Bruker AV 400 MHz using DMSO
as a solvent and TMS as an internal standard.
2.1. Preparation of chalcone derivatives (1a–e)
A mixture of 40-piperazine acetophenone (0.01 mole) and aryl
aldehyde (0.01 mole) was stirred in methanol (15 ml), then an
aqueous solution of 40%KOH (10 ml) was added. The mixture
was kept overnight at room temperature, poured into crushed
ice and then acidiﬁed with HCl. The solid separated was ﬁltered
and crystallized from ethylacetate and methanol mixture (8:2).
2.2. General procedure for the preparation of pyrimidines RP (1–5)
A mixture of appropriate chalcones of 1a–e (1 e.q.) and guani-
dine hydrochloride (1 e.q.) in absolute ethanol (10 ml) was
256 Sk.A. Rahaman et al.reﬂuxed on a water bath for 6 h (Meazza et al., 1993). The sol-
vent was completely evaporated and the residue was poured
into ice cold water. The precipitated solid was collected by ﬁl-
tration, puriﬁed on silica gel column using methanol and eth-
ylacetate mixture (1:9) solvent system.
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N2.3. Estimation of anti-histaminic activity
Anti-histaminic activity of the synthesized pyrimidine deriva-
tives was estimated on guinea pigs of either sex 400–550 mg.
They were sacriﬁced by stunning and exsanguinations (Kulk-
arni, 2002). The abdomen of guinea pig was opened with scis-
sors and the caecum was lifted to trace the illeo-caecal
junction. A required length of the long ileal portion was cut,
removed and immediately placed on the watch glass containing
tyrode solution. Then the mesentery was trimmed and the con-
tents of the ileum were cleaned by pumping the tyrode solution
into the lumen of the ileum. The ileum was cut into small seg-
ments of 2–3 cm long. One piece of ileum was taken and a
thread was tied to top and bottom ends without closing the lu-
men and the tissue was mounted in the organ bath containingTable 1 Characterization data of compounds RP (1–5).
Compound Molecular formula
RP 1 C20H20N5Br
RP 2 C28H25N5
RP 3 C21H23N5
RP 4 C20H21N5O
RP 5 C20H21N5tyrode solution. The organ bath temperature was maintained
at 37 C and bubbled with oxygen air. A tension of 0.5 g was
applied and the tissue was allowed to equilibrate for 30 min be-
fore adding drugs to the organ bath.
The concentration dependent responses due to histamine
were recorded using frontal writing lever. A contact time of
30 s and 5 min time cycle were kept for proper recording of
the responses. Initially histamine dose was given with a con-
centration of 0.1 lg/ml, then 0.2 lg/ml, 0.4 lg/ml and 0.8 lg/
ml. Among these concentrations 0.4 lg/ml was selected as sub-
maximal dose.
2.4. Test solution preparation
10 mg of each test sample was dissolved in 10 ml DMSO sol-
vent. The resulting solutions were diluted with DNS (dextrose
normal saline) solution to get concentrations of 0.1 lg/ml,
0.2 lg/ml, 0.4 lg/ml and 0.8 lg/ml.
2.5. Standard solution preparation
Ten milligrams of sample were dissolved in 10 ml DNS solu-
tion. Then different dilutions of standard solution were pre-
pared to get concentrations of 0.1 lg/ml, 0.2 lg/ml, 0.4 lg/ml
and 0.8 lg/ml.
The responses were recorded on a kymograph. The graph
was plotted taking the concentration of test/standard on X-
axis and % inhibition on Y axis (see Tables 1 and 2).
Formula for calculation:
% Inhibition ¼ a b
a
 100
where a is the height of the histamine response (in cm) and b is
the height of test/standard response (in cm).
By using the above-mentioned formula percentage of hista-
mine inhibition was calculated and the values are given in Ta-
ble 3.3. Results and discussion
To prepare new pyrimidine derivatives we used chalcone as a
starting material. Chalcones are 1,3-diaryl-2-propene-1-ones.
In the present communication, we reported that the reaction
between different chalcone derivatives (1a–e) and guanidine
HCl (2) gives pyrimidine derivatives RP (1–5). The structures
of various synthesized compounds were assigned on the basis
of elemental analysis, IR, 1H NMR and mass spectral analysis.
These compounds were also screened for their anti-histaminic
activity.M.wt. M.P. (C) Yield (%)
407 107–108 64.5
431.4 145–148 82
345 95–98 77.4
347 144–145 71.5
331 135–137 85.7
Table 2 IR and 1H NMR Spectral data of compounds RP 1–5.
Compound IR (cm1) (KBr) 1H NMR (DMSO) (d ppm)
RP 1 (i) N–H str – 3341 1.867 (1H, s, aliphatic N–H)
(ii) C‚N str – 1598 2.507 and 2.880 (8H, piperazine protons)
(iii) C‚C str – 1564 4.263 (2H, bs, 1NH2), 8.423 (1H, s, C–5H)
(iv) C–Br str – 536 6.646 (1H, s, C–21H), 6.929–8.236 (7H, aromatic protons)
RP 2 (i) N–H str – 3392 1.873 (1H, s, aliphatic N–H)
(ii) C‚N str – 1602 2.507 and 2.853 (8H, piperazine protons)
(iii) C‚C str – 1567 4.145 (2H, bs, 1NH2), 7.208 (1H, s, C–5H), 6.751–8.699 (13H, aromatic protons)
RP 3 (i) N–H str – 3398 1.879 (1H, s, aliphatic N–H),
(ii) C‚N str – 1603 2.506 and 2.877 (8H, piperazine protons)
(iii) C‚C str – 1575 2.377 (3H, s, benzylic protons), 3.740 (2H, bs, 1NH2)
7.564 (1H, s, C–5H), 6.520–8.110 (8H, aromatic protons)
RP 4 (i) N–H str – 3400 1.894 (1H, bs, aliphatic N–H)
(ii) C‚N str – 1572 2.506 and 2.99 (8H, piperazine protons)
(iii) C–Cl str – 655 3.939 (2H, bs, 1NH2), 7.482 (1H, s, C–5H)
6.375 (1H, s, C–20OH), 6.732–8.113 (8H, aromatic protons)
RP 5 (i) N–H str – 3405 1.871 (1H, s, aliphatic N–H)
(ii) C‚N str – 1602 2.506 and 2.865 (8H, piperazine protons)
(iii) C‚C str – 1575 3.999 (2H, bs, 1NH2), 7.606 (1H, s, C–5H)
6.584–7.838 (9H, aromatic protons)
Table 3 Percentage of histamine inhibition of the newly synthesized pyrimidines RP (1–5).
Tested compound % Inhibition
0.1 lg 0.2 lg 0.4 lg 0.8 lg
RP 1 9.5 33.33 46.66 60
RP 2 0 2.1 27.4 42.6
RP 3 3.2 12.4 29.81 49.32
RP 4 10.81 41.8 51.94 67.4
RP 5 0 0 14.8 29.5
Mepiramine 17.6 100 100 100
DMSO was used as a control.
Synthesis and anti-histaminic activity of some novel pyrimidines 257The newly synthesized pyrimidines showed signiﬁcant anti-
histaminic activity. If the concentration of pyrimidine deriva-
tives RP (1–5) increases, the percentage of histamine inhibition
also increases. Among the ﬁve pyrimidine derivatives RP (1–5),
only bromine-substituted and 2-hydroxyphenyl-substituted
pyrimidines showed greater anti-histaminic activity.Acknowledgements
The authors are thankful to the principal and management of
K.V.S.R. Siddhartha College of Pharmaceutical Sciences for
providing proper facilities to carry out the research work
and Laila Impex Ltd., Vijayawada, AP, India, for providing
the 1H NMR, IR and mass spectral analysis.
References
Ahluwalia, V.K., Nayal, L., Kalia, N., Bala, S., Tahim, A.K., 1987.
Synthesis and antimicrobial activity of substituted 3,4-dihydro-2H-
1-benzopyrans. Indian J. Chem. 26B (4), 384–386.
Bhat, A.K., Bhamana, R.P., Patel, M.R., Bellare, R.A., Deliwala,
C.V., 1972. Chemotherapy of fungus infections. III. Alkyl or aryl
thiosemicarbazones, acid hydrazones, and styryl aryl ketones of
5-bromo- and 5-nitrosalicylaldehydes. Indian J. Chem. 10 (7),
694–698.Hogale, M.B., Dhore, N.P., Shelar, A.R., Pawar, P.K., 1986. Synthesis
and biological activity of some urethane derivatives of chalcones.
Orient. J. Chem. 2, 55–57.
Ishitsuka, H., Ninomiya, Y.T., Ohsawa, C., Fujiu, M., Suhara, Y.,
1982. Direct and speciﬁc inactivation of rhinovirus by chalcone Ro
09-0410. Antimicrob. Agents Chemother. 22 (4), 617–621.
Isida, S., Matsuda, A., Kawamura, Y., Yamanaka, K., 1960.
Antifungal agent. I. Antibacterial and antifungal activities
in vitro of several organic compounds. Chromatography (Tokyo)
8, 146–151.
Kulkarni, S., 2002. A Handbook of Experimental Pharmacology.
Springer Science, Berlin, Germany, pp. 23–25.
Mattew, J., Subba Rao, A.V., Rambhav, S., 1984. Propterol – an
antibacterial agent from Pterocarpus marsupium. Curr. Sci. 53 (11),
576–577.
Meazza, G., Zanardi, G., Piccardi, P.A., 1993. convenient and versatile
synthesis of 4-triﬂuoromethyl-substituted pyrazoles. J. Heterocyclic
Chem. 30, 365–371.
Ninomiya, Y., Shimma, N., Ishitsuka, H., 1990. Comparative studies
on the antirhinovirus activity and the mode of action of the
rhinovirus capsid binding agents, chalcone amides. Antiviral Res.
13 (2), 61–74.
Yamakawa, T., Kagechika, H., Kawachi, E., Hashimoto, Y., Shedo,
K., 1990. Retinobenzoic acids. 5. Retinoidal activities of com-
pounds having a trimethylsilyl or trim-ethylgermyl group(s) in
human promyelocytic leukemia cells HL-60. J. Med. Chem. 33 (5),
1430–1437.
258 Sk.A. Rahaman et al.
